speb/financial-data huggingface dataset:
CNS.V cash_flow (quarterly, 2024-12-31) — Change In Payables And Accrued Expense: -19214.00
CNS.V cash_flow (quarterly, 2024-12-31) — Change In Receivables: -2480.00
CNS.V cash_flow (quarterly, 2024-12-31) — Change In Working Capital: -21694.00
CNS.V cash_flow (quarterly, 2024-12-31) — Changes In Account Receivables: -2480.00
CNS.V cash_flow (quarterly, 2024-12-31) — Changes In Cash: 814.00
CNS.V balance_sheet (quarterly, 2024-12-31) — Common Stock: 22259191.00
CNS.V balance_sheet (quarterly, 2024-12-31) — Common Stock Equity: -1699667.00
CNS.V balance_sheet (quarterly, 2024-12-31) — Current Accrued Expenses: 101853.00
CNS.V balance_sheet (quarterly, 2024-12-31) — Current Assets: 4297.00
CNS.V balance_sheet (quarterly, 2024-12-31) — Current Debt: 300000.00
CNS.V balance_sheet (quarterly, 2024-12-31) — Current Debt And Capital Lease Obligation: 300000.00
CNS.V balance_sheet (quarterly, 2024-12-31) — Current Liabilities: 1703964.00
CNS.V income_statement (quarterly, 2024-12-31) — Diluted Average Shares: 94036835.00
CNS.V income_statement (quarterly, 2024-12-31) — Diluted EPS: 0.00
CNS.V income_statement (quarterly, 2024-12-31) — Diluted NI Availto Com Stockholders: -14803.00
CNS.V balance_sheet (quarterly, 2024-12-31) — Dueto Related Parties Current: 494862.00
CNS.V income_statement (quarterly, 2024-12-31) — EBIT: -8803.00
CNS.V income_statement (quarterly, 2024-12-31) — EBITDA: -8803.00
CNS.V cash_flow (quarterly, 2024-12-31) — End Cash Position: 911.00
CNS.V cash_flow (quarterly, 2024-12-31) — Financing Cash Flow: 37311.00
CNS.V cash_flow (quarterly, 2024-12-31) — Free Cash Flow: -36497.00
CNS.V balance_sheet (quarterly, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: 3166013.00
CNS.V income_statement (quarterly, 2024-12-31) — General And Administrative Expense: 8803.00
CNS.V income_statement (quarterly, 2024-12-31) — Interest Expense: 6000.00
CNS.V income_statement (quarterly, 2024-12-31) — Interest Expense Non Operating: 6000.00
CNS.V balance_sheet (quarterly, 2024-12-31) — Interest Payable: 101853.00
CNS.V balance_sheet (quarterly, 2024-12-31) — Invested Capital: -1399667.00
CNS.V balance_sheet (quarterly, 2024-12-31) — Net Debt: 299089.00
CNS.V income_statement (quarterly, 2024-12-31) — Net Income: -14803.00
CNS.V income_statement (quarterly, 2024-12-31) — Net Income Common Stockholders: -14803.00
CNS.V income_statement (quarterly, 2024-12-31) — Net Income Continuous Operations: -14803.00
CNS.V income_statement (quarterly, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -14803.00
CNS.V income_statement (quarterly, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -14803.00
CNS.V cash_flow (quarterly, 2024-12-31) — Net Income From Continuing Operations: -14803.00
CNS.V income_statement (quarterly, 2024-12-31) — Net Income Including Noncontrolling Interests: -14803.00
CNS.V income_statement (quarterly, 2024-12-31) — Net Interest Income: -6000.00
CNS.V income_statement (quarterly, 2024-12-31) — Net Non Operating Interest Income Expense: -6000.00
CNS.V balance_sheet (quarterly, 2024-12-31) — Net Tangible Assets: -1699667.00
CNS.V income_statement (quarterly, 2024-12-31) — Normalized EBITDA: -8803.00
CNS.V income_statement (quarterly, 2024-12-31) — Normalized Income: -14803.00
CNS.V cash_flow (quarterly, 2024-12-31) — Operating Cash Flow: -36497.00
CNS.V income_statement (quarterly, 2024-12-31) — Operating Income: -8803.00
CNS.V income_statement (quarterly, 2024-12-31) — Operating Revenue: 0.00
CNS.V balance_sheet (quarterly, 2024-12-31) — Ordinary Shares Number: 94036835.00
CNS.V balance_sheet (quarterly, 2024-12-31) — Other Current Borrowings: 300000.00
CNS.V income_statement (quarterly, 2024-12-31) — Other Gand A: 8803.00
CNS.V balance_sheet (quarterly, 2024-12-31) — Other Receivables: 3386.00
CNS.V balance_sheet (quarterly, 2024-12-31) — Payables: 1302111.00
CNS.V balance_sheet (quarterly, 2024-12-31) — Payables And Accrued Expenses: 1403964.00
CNS.V income_statement (quarterly, 2024-12-31) — Pretax Income: -14803.00
CNS.V balance_sheet (quarterly, 2024-12-31) — Receivables: 3386.00
CNS.V balance_sheet (quarterly, 2024-12-31) — Retained Earnings: -27124871.00
CNS.V income_statement (quarterly, 2024-12-31) — Selling General And Administration: 8803.00
CNS.V balance_sheet (quarterly, 2024-12-31) — Share Issued: 94036835.00
CNS.V balance_sheet (quarterly, 2024-12-31) — Stockholders Equity: -1699667.00
CNS.V balance_sheet (quarterly, 2024-12-31) — Tangible Book Value: -1699667.00
CNS.V income_statement (quarterly, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
CNS.V income_statement (quarterly, 2024-12-31) — Tax Rate For Calcs: 0.00
CNS.V balance_sheet (quarterly, 2024-12-31) — Total Assets: 4297.00
CNS.V balance_sheet (quarterly, 2024-12-31) — Total Capitalization: -1699667.00
CNS.V balance_sheet (quarterly, 2024-12-31) — Total Debt: 300000.00
CNS.V balance_sheet (quarterly, 2024-12-31) — Total Equity Gross Minority Interest: -1699667.00
CNS.V income_statement (quarterly, 2024-12-31) — Total Expenses: 8803.00
CNS.V balance_sheet (quarterly, 2024-12-31) — Total Liabilities Net Minority Interest: 1703964.00
CNS.V balance_sheet (quarterly, 2024-12-31) — Total Non Current Assets: 0.00
CNS.V balance_sheet (quarterly, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 0.00
CNS.V balance_sheet (quarterly, 2024-12-31) — Working Capital: -1699667.00
CNS.V income_statement (annual, 2025-03-31) — +Operating Expense: 74583.00
CNS.V income_statement (quarterly, 2025-03-31) — +Operating Expense: 13620.00
CNS.V income_statement (annual, 2025-03-31) — +Total Revenue: 0.00
CNS.V income_statement (quarterly, 2025-03-31) — +Total Revenue: 0.00
CNS.V balance_sheet (annual, 2025-03-31) — Accounts Payable: 795788.00
CNS.V balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 795788.00
CNS.V income_statement (annual, 2025-03-31) — Basic Average Shares: 94036835.00
CNS.V income_statement (annual, 2025-03-31) — Basic EPS: 0.00
CNS.V cash_flow (annual, 2025-03-31) — Beginning Cash Position: 4516.00
CNS.V cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 911.00
CNS.V balance_sheet (annual, 2025-03-31) — Capital Stock: 22259191.00
CNS.V balance_sheet (quarterly, 2025-03-31) — Capital Stock: 22259191.00
CNS.V balance_sheet (annual, 2025-03-31) — Cash And Cash Equivalents: 10328.00
CNS.V balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 10328.00
CNS.V balance_sheet (annual, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 10328.00
CNS.V balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 10328.00
CNS.V balance_sheet (annual, 2025-03-31) — Cash Financial: 10328.00
CNS.V balance_sheet (quarterly, 2025-03-31) — Cash Financial: 10328.00
CNS.V cash_flow (annual, 2025-03-31) — Cash Flow From Continuing Financing Activities: 70311.00
CNS.V cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: 33000.00
CNS.V cash_flow (annual, 2025-03-31) — Cash Flow From Continuing Operating Activities: -64499.00
CNS.V cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: -23583.00
CNS.V cash_flow (annual, 2025-03-31) — Change In Account Payable: 8087.00
CNS.V cash_flow (quarterly, 2025-03-31) — Change In Account Payable: -11461.00
CNS.V cash_flow (annual, 2025-03-31) — Change In Accrued Expense: 24000.00
CNS.V cash_flow (quarterly, 2025-03-31) — Change In Accrued Expense: 6114.00
CNS.V cash_flow (annual, 2025-03-31) — Change In Interest Payable: 24000.00
CNS.V cash_flow (quarterly, 2025-03-31) — Change In Interest Payable: 6114.00
CNS.V cash_flow (annual, 2025-03-31) — Change In Payable: 8087.00
CNS.V cash_flow (quarterly, 2025-03-31) — Change In Payable: -11461.00
CNS.V cash_flow (annual, 2025-03-31) — Change In Payables And Accrued Expense: 32087.00
CNS.V cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: -5347.00
CNS.V cash_flow (annual, 2025-03-31) — Change In Receivables: 1981.00
CNS.V cash_flow (quarterly, 2025-03-31) — Change In Receivables: 1482.00
CNS.V cash_flow (annual, 2025-03-31) — Change In Working Capital: 34068.00
CNS.V cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -3865.00
CNS.V cash_flow (annual, 2025-03-31) — Changes In Account Receivables: 1981.00
CNS.V cash_flow (quarterly, 2025-03-31) — Changes In Account Receivables: 1482.00
CNS.V cash_flow (annual, 2025-03-31) — Changes In Cash: 5812.00
CNS.V cash_flow (quarterly, 2025-03-31) — Changes In Cash: 9417.00
CNS.V balance_sheet (annual, 2025-03-31) — Common Stock: 22259191.00
CNS.V balance_sheet (quarterly, 2025-03-31) — Common Stock: 22259191.00
CNS.V balance_sheet (annual, 2025-03-31) — Common Stock Equity: -1719385.00
CNS.V balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: -1719385.00
CNS.V balance_sheet (annual, 2025-03-31) — Current Accrued Expenses: 107967.00
CNS.V balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 107967.00
CNS.V balance_sheet (annual, 2025-03-31) — Current Assets: 12232.00
CNS.V balance_sheet (quarterly, 2025-03-31) — Current Assets: 12232.00
CNS.V balance_sheet (annual, 2025-03-31) — Current Debt: 333000.00
CNS.V balance_sheet (quarterly, 2025-03-31) — Current Debt: 333000.00
CNS.V balance_sheet (annual, 2025-03-31) — Current Debt And Capital Lease Obligation: 333000.00
CNS.V balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 333000.00
CNS.V balance_sheet (annual, 2025-03-31) — Current Liabilities: 1731617.00
CNS.V balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 1731617.00
CNS.V income_statement (annual, 2025-03-31) — Diluted Average Shares: 94036835.00
CNS.V income_statement (annual, 2025-03-31) — Diluted EPS: 0.00
CNS.V income_statement (annual, 2025-03-31) — Diluted NI Availto Com Stockholders: -98567.00
CNS.V income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: -19718.00
CNS.V balance_sheet (annual, 2025-03-31) — Dueto Related Parties Current: 494862.00
CNS.V balance_sheet (quarterly, 2025-03-31) — Dueto Related Parties Current: 494862.00
CNS.V income_statement (annual, 2025-03-31) — EBIT: -74583.00
CNS.V income_statement (quarterly, 2025-03-31) — EBIT: -13620.00
CNS.V income_statement (annual, 2025-03-31) — EBITDA: -74583.00
CNS.V income_statement (quarterly, 2025-03-31) — EBITDA: -13620.00
CNS.V cash_flow (annual, 2025-03-31) — End Cash Position: 10328.00
CNS.V cash_flow (quarterly, 2025-03-31) — End Cash Position: 10328.00
CNS.V cash_flow (annual, 2025-03-31) — Financing Cash Flow: 70311.00
CNS.V cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: 33000.00
CNS.V cash_flow (annual, 2025-03-31) — Free Cash Flow: -64499.00
CNS.V cash_flow (quarterly, 2025-03-31) — Free Cash Flow: -23583.00
CNS.V balance_sheet (annual, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: 3166013.00
CNS.V balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: 3166013.00
CNS.V income_statement (annual, 2025-03-31) — General And Administrative Expense: 74583.00
CNS.V income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 13620.00
CNS.V income_statement (annual, 2025-03-31) — Interest Expense: 23984.00
CNS.V income_statement (quarterly, 2025-03-31) — Interest Expense: 6098.00
CNS.V income_statement (annual, 2025-03-31) — Interest Expense Non Operating: 23984.00
CNS.V income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 6098.00
CNS.V balance_sheet (annual, 2025-03-31) — Interest Payable: 107967.00
CNS.V balance_sheet (quarterly, 2025-03-31) — Interest Payable: 107967.00
CNS.V balance_sheet (annual, 2025-03-31) — Invested Capital: -1386385.00
CNS.V balance_sheet (quarterly, 2025-03-31) — Invested Capital: -1386385.00
CNS.V cash_flow (annual, 2025-03-31) — Issuance Of Debt: 33000.00
CNS.V balance_sheet (annual, 2025-03-31) — Net Debt: 322672.00
CNS.V balance_sheet (quarterly, 2025-03-31) — Net Debt: 322672.00
CNS.V income_statement (annual, 2025-03-31) — Net Income: -98567.00
CNS.V income_statement (quarterly, 2025-03-31) — Net Income: -19718.00
CNS.V income_statement (annual, 2025-03-31) — Net Income Common Stockholders: -98567.00
CNS.V income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: -19718.00
CNS.V income_statement (annual, 2025-03-31) — Net Income Continuous Operations: -98567.00
CNS.V income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: -19718.00
CNS.V income_statement (annual, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -98567.00
CNS.V income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -19718.00
CNS.V income_statement (annual, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -98567.00
CNS.V income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -19718.00
CNS.V cash_flow (annual, 2025-03-31) — Net Income From Continuing Operations: -98567.00
CNS.V cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: -19718.00
CNS.V income_statement (annual, 2025-03-31) — Net Income Including Noncontrolling Interests: -98567.00
CNS.V income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: -19718.00
CNS.V income_statement (annual, 2025-03-31) — Net Interest Income: -23984.00
CNS.V income_statement (quarterly, 2025-03-31) — Net Interest Income: -6098.00
CNS.V cash_flow (annual, 2025-03-31) — Net Issuance Payments Of Debt: 33000.00
CNS.V income_statement (annual, 2025-03-31) — Net Non Operating Interest Income Expense: -23984.00
CNS.V income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -6098.00
CNS.V cash_flow (annual, 2025-03-31) — Net Other Financing Charges: 37311.00
CNS.V cash_flow (quarterly, 2025-03-31) — Net Other Financing Charges: 0.00
CNS.V cash_flow (annual, 2025-03-31) — Net Short Term Debt Issuance: 33000.00
CNS.V balance_sheet (annual, 2025-03-31) — Net Tangible Assets: -1719385.00
CNS.V balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: -1719385.00
CNS.V income_statement (annual, 2025-03-31) — Normalized EBITDA: -74583.00
CNS.V income_statement (quarterly, 2025-03-31) — Normalized EBITDA: -13620.00
CNS.V income_statement (annual, 2025-03-31) — Normalized Income: -98567.00
CNS.V income_statement (quarterly, 2025-03-31) — Normalized Income: -19718.00
CNS.V cash_flow (annual, 2025-03-31) — Operating Cash Flow: -64499.00
CNS.V cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: -23583.00
CNS.V income_statement (annual, 2025-03-31) — Operating Income: -74583.00
CNS.V income_statement (quarterly, 2025-03-31) — Operating Income: -13620.00
CNS.V income_statement (annual, 2025-03-31) — Operating Revenue: 0.00
CNS.V income_statement (quarterly, 2025-03-31) — Operating Revenue: 0.00
CNS.V balance_sheet (annual, 2025-03-31) — Ordinary Shares Number: 94036835.00
CNS.V balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 94036835.00
CNS.V balance_sheet (annual, 2025-03-31) — Other Current Borrowings: 333000.00
CNS.V balance_sheet (quarterly, 2025-03-31) — Other Current Borrowings: 333000.00
CNS.V income_statement (annual, 2025-03-31) — Other Gand A: 74583.00
CNS.V income_statement (quarterly, 2025-03-31) — Other Gand A: 13620.00
CNS.V balance_sheet (annual, 2025-03-31) — Other Receivables: 1904.00
CNS.V balance_sheet (quarterly, 2025-03-31) — Other Receivables: 1904.00
CNS.V balance_sheet (annual, 2025-03-31) — Payables: 1290650.00
CNS.V balance_sheet (quarterly, 2025-03-31) — Payables: 1290650.00
CNS.V balance_sheet (annual, 2025-03-31) — Payables And Accrued Expenses: 1398617.00
CNS.V balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 1398617.00
CNS.V income_statement (annual, 2025-03-31) — Pretax Income: -98567.00
CNS.V income_statement (quarterly, 2025-03-31) — Pretax Income: -19718.00
CNS.V balance_sheet (annual, 2025-03-31) — Receivables: 1904.00
CNS.V balance_sheet (quarterly, 2025-03-31) — Receivables: 1904.00
CNS.V balance_sheet (annual, 2025-03-31) — Retained Earnings: -27144589.00
CNS.V balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -27144589.00
CNS.V income_statement (annual, 2025-03-31) — Selling General And Administration: 74583.00
CNS.V income_statement (quarterly, 2025-03-31) — Selling General And Administration: 13620.00
CNS.V balance_sheet (annual, 2025-03-31) — Share Issued: 94036835.00
CNS.V balance_sheet (quarterly, 2025-03-31) — Share Issued: 94036835.00
CNS.V cash_flow (annual, 2025-03-31) — Short Term Debt Issuance: 33000.00
CNS.V income_statement (annual, 2025-03-31) — Special Income Charges: 0.00
CNS.V balance_sheet (annual, 2025-03-31) — Stockholders Equity: -1719385.00
CNS.V balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: -1719385.00
CNS.V balance_sheet (annual, 2025-03-31) — Tangible Book Value: -1719385.00
CNS.V balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: -1719385.00
CNS.V income_statement (annual, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
CNS.V income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
CNS.V income_statement (annual, 2025-03-31) — Tax Rate For Calcs: 0.00
CNS.V income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.00
CNS.V balance_sheet (annual, 2025-03-31) — Total Assets: 12232.00
CNS.V balance_sheet (quarterly, 2025-03-31) — Total Assets: 12232.00
CNS.V balance_sheet (annual, 2025-03-31) — Total Capitalization: -1719385.00
CNS.V balance_sheet (quarterly, 2025-03-31) — Total Capitalization: -1719385.00
CNS.V balance_sheet (annual, 2025-03-31) — Total Debt: 333000.00
CNS.V balance_sheet (quarterly, 2025-03-31) — Total Debt: 333000.00
CNS.V balance_sheet (annual, 2025-03-31) — Total Equity Gross Minority Interest: -1719385.00
CNS.V balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: -1719385.00
CNS.V income_statement (annual, 2025-03-31) — Total Expenses: 74583.00
CNS.V income_statement (quarterly, 2025-03-31) — Total Expenses: 13620.00
CNS.V balance_sheet (annual, 2025-03-31) — Total Liabilities Net Minority Interest: 1731617.00
CNS.V balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 1731617.00
CNS.V balance_sheet (annual, 2025-03-31) — Total Non Current Assets: 0.00
CNS.V balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 0.00
CNS.V balance_sheet (annual, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 0.00
CNS.V balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 0.00
CNS.V income_statement (annual, 2025-03-31) — Total Unusual Items: 0.00
CNS.V income_statement (annual, 2025-03-31) — Total Unusual Items Excluding Goodwill: 0.00
CNS.V balance_sheet (annual, 2025-03-31) — Working Capital: -1719385.00
CNS.V balance_sheet (quarterly, 2025-03-31) — Working Capital: -1719385.00
CNS.V income_statement (quarterly, 2025-06-30) — +Operating Expense: 8168.00
CNS.V income_statement (quarterly, 2025-06-30) — +Total Revenue: 0.00
CNS.V balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 800821.00
CNS.V income_statement (quarterly, 2025-06-30) — Basic Average Shares: 94036835.00
CNS.V income_statement (quarterly, 2025-06-30) — Basic EPS: 0.00
CNS.V cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 10328.00
CNS.V balance_sheet (quarterly, 2025-06-30) — Capital Stock: 22259191.00
CNS.V balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 7115.00
CNS.V balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 7115.00
CNS.V balance_sheet (quarterly, 2025-06-30) — Cash Financial: 7115.00
CNS.V cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: -3213.00
CNS.V cash_flow (quarterly, 2025-06-30) — Change In Account Payable: 5033.00
CNS.V cash_flow (quarterly, 2025-06-30) — Change In Accrued Expense: 6000.00
CNS.V cash_flow (quarterly, 2025-06-30) — Change In Interest Payable: 6000.00
CNS.V cash_flow (quarterly, 2025-06-30) — Change In Payable: 5033.00
CNS.V cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: 11033.00
CNS.V cash_flow (quarterly, 2025-06-30) — Change In Receivables: -94.00
CNS.V cash_flow (quarterly, 2025-06-30) — Change In Working Capital: 10939.00
CNS.V cash_flow (quarterly, 2025-06-30) — Changes In Account Receivables: -94.00
CNS.V cash_flow (quarterly, 2025-06-30) — Changes In Cash: -3213.00
CNS.V balance_sheet (quarterly, 2025-06-30) — Common Stock: 22259191.00
CNS.V balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: -1733537.00
CNS.V balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 113967.00
CNS.V balance_sheet (quarterly, 2025-06-30) — Current Assets: 9113.00
CNS.V balance_sheet (quarterly, 2025-06-30) — Current Debt: 333000.00
CNS.V balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 333000.00
CNS.V balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 1742650.00
CNS.V income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 94036835.00
CNS.V income_statement (quarterly, 2025-06-30) — Diluted EPS: 0.00
CNS.V income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: -14152.00
CNS.V balance_sheet (quarterly, 2025-06-30) — Dueto Related Parties Current: 494862.00
CNS.V income_statement (quarterly, 2025-06-30) — EBIT: -8168.00
CNS.V income_statement (quarterly, 2025-06-30) — EBITDA: -8168.00
CNS.V cash_flow (quarterly, 2025-06-30) — End Cash Position: 7115.00
CNS.V cash_flow (quarterly, 2025-06-30) — Free Cash Flow: -3213.00
CNS.V balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: 3166013.00
CNS.V income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 8168.00
CNS.V income_statement (quarterly, 2025-06-30) — Interest Expense: 5984.00
CNS.V income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 5984.00
CNS.V balance_sheet (quarterly, 2025-06-30) — Interest Payable: 113967.00
CNS.V balance_sheet (quarterly, 2025-06-30) — Invested Capital: -1400537.00
CNS.V balance_sheet (quarterly, 2025-06-30) — Net Debt: 325885.00
CNS.V income_statement (quarterly, 2025-06-30) — Net Income: -14152.00
CNS.V income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: -14152.00
CNS.V income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: -14152.00
CNS.V income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: -14152.00
CNS.V income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: -14152.00
CNS.V cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: -14152.00
CNS.V income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: -14152.00
CNS.V income_statement (quarterly, 2025-06-30) — Net Interest Income: -5984.00
CNS.V income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -5984.00
CNS.V balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: -1733537.00
CNS.V income_statement (quarterly, 2025-06-30) — Normalized EBITDA: -8168.00
CNS.V income_statement (quarterly, 2025-06-30) — Normalized Income: -14152.00
CNS.V cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: -3213.00
CNS.V income_statement (quarterly, 2025-06-30) — Operating Income: -8168.00
CNS.V income_statement (quarterly, 2025-06-30) — Operating Revenue: 0.00
CNS.V balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 94036835.00
CNS.V balance_sheet (quarterly, 2025-06-30) — Other Current Borrowings: 333000.00
CNS.V income_statement (quarterly, 2025-06-30) — Other Gand A: 8168.00
CNS.V balance_sheet (quarterly, 2025-06-30) — Other Receivables: 1998.00
CNS.V balance_sheet (quarterly, 2025-06-30) — Payables: 1295683.00
CNS.V balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 1409650.00
CNS.V income_statement (quarterly, 2025-06-30) — Pretax Income: -14152.00
CNS.V balance_sheet (quarterly, 2025-06-30) — Receivables: 1998.00
CNS.V balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -27158741.00
CNS.V income_statement (quarterly, 2025-06-30) — Selling General And Administration: 8168.00
CNS.V balance_sheet (quarterly, 2025-06-30) — Share Issued: 94036835.00
CNS.V balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: -1733537.00
CNS.V balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: -1733537.00
CNS.V income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
CNS.V income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.00
CNS.V balance_sheet (quarterly, 2025-06-30) — Total Assets: 9113.00
CNS.V balance_sheet (quarterly, 2025-06-30) — Total Capitalization: -1733537.00
CNS.V balance_sheet (quarterly, 2025-06-30) — Total Debt: 333000.00
CNS.V balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: -1733537.00
CNS.V income_statement (quarterly, 2025-06-30) — Total Expenses: 8168.00
CNS.V balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 1742650.00
CNS.V balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 0.00
CNS.V balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 0.00
CNS.V balance_sheet (quarterly, 2025-06-30) — Working Capital: -1733537.00
CNS.V income_statement (quarterly, 2025-09-30) — +Operating Expense: 4746.00
CNS.V income_statement (quarterly, 2025-09-30) — +Total Revenue: 0.00
CNS.V balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 803651.00
CNS.V income_statement (quarterly, 2025-09-30) — Basic Average Shares: 94036835.00
CNS.V income_statement (quarterly, 2025-09-30) — Basic EPS: 0.00
CNS.V cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 7115.00
CNS.V balance_sheet (quarterly, 2025-09-30) — Capital Stock: 22259191.00
CNS.V balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 5098.00
CNS.V balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 5098.00
CNS.V balance_sheet (quarterly, 2025-09-30) — Cash Financial: 5098.00
CNS.V cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: -2017.00
CNS.V cash_flow (quarterly, 2025-09-30) — Change In Account Payable: 2830.00
CNS.V cash_flow (quarterly, 2025-09-30) — Change In Accrued Expense: 5984.00
CNS.V cash_flow (quarterly, 2025-09-30) — Change In Interest Payable: 5984.00
CNS.V cash_flow (quarterly, 2025-09-30) — Change In Payable: 2830.00
CNS.V cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: 8814.00
CNS.V cash_flow (quarterly, 2025-09-30) — Change In Receivables: -85.00
CNS.V cash_flow (quarterly, 2025-09-30) — Change In Working Capital: 8729.00
CNS.V cash_flow (quarterly, 2025-09-30) — Changes In Account Receivables: -85.00
CNS.V cash_flow (quarterly, 2025-09-30) — Changes In Cash: -2017.00
CNS.V balance_sheet (quarterly, 2025-09-30) — Common Stock: 22259191.00
CNS.V balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: -1744283.00
CNS.V balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 119951.00
CNS.V balance_sheet (quarterly, 2025-09-30) — Current Assets: 7181.00
CNS.V balance_sheet (quarterly, 2025-09-30) — Current Debt: 333000.00
CNS.V balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 333000.00
CNS.V balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 1751464.00
CNS.V income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 94036835.00
CNS.V income_statement (quarterly, 2025-09-30) — Diluted EPS: 0.00
CNS.V income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: -10746.00
CNS.V balance_sheet (quarterly, 2025-09-30) — Dueto Related Parties Current: 494862.00
CNS.V income_statement (quarterly, 2025-09-30) — EBIT: -4746.00
CNS.V income_statement (quarterly, 2025-09-30) — EBITDA: -4746.00
CNS.V cash_flow (quarterly, 2025-09-30) — End Cash Position: 5098.00
CNS.V cash_flow (quarterly, 2025-09-30) — Free Cash Flow: -2017.00
CNS.V balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: 3166013.00
CNS.V income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 4746.00
CNS.V income_statement (quarterly, 2025-09-30) — Interest Expense: 6000.00
CNS.V income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 6000.00
CNS.V balance_sheet (quarterly, 2025-09-30) — Interest Payable: 119951.00
CNS.V balance_sheet (quarterly, 2025-09-30) — Invested Capital: -1411283.00
CNS.V balance_sheet (quarterly, 2025-09-30) — Net Debt: 327902.00
CNS.V income_statement (quarterly, 2025-09-30) — Net Income: -10746.00
CNS.V income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: -10746.00
CNS.V income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: -10746.00
CNS.V income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: -10746.00
CNS.V income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: -10746.00
CNS.V cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: -10746.00
CNS.V income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: -10746.00
CNS.V income_statement (quarterly, 2025-09-30) — Net Interest Income: -6000.00
CNS.V income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -6000.00
CNS.V balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: -1744283.00
CNS.V income_statement (quarterly, 2025-09-30) — Normalized EBITDA: -4746.00
CNS.V income_statement (quarterly, 2025-09-30) — Normalized Income: -10746.00
CNS.V cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: -2017.00
CNS.V income_statement (quarterly, 2025-09-30) — Operating Income: -4746.00
CNS.V income_statement (quarterly, 2025-09-30) — Operating Revenue: 0.00
CNS.V balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 94036835.00
CNS.V balance_sheet (quarterly, 2025-09-30) — Other Current Borrowings: 333000.00
CNS.V income_statement (quarterly, 2025-09-30) — Other Gand A: 4746.00
CNS.V balance_sheet (quarterly, 2025-09-30) — Other Receivables: 2083.00
CNS.V balance_sheet (quarterly, 2025-09-30) — Payables: 1298513.00
CNS.V balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 1418464.00
CNS.V income_statement (quarterly, 2025-09-30) — Pretax Income: -10746.00
CNS.V balance_sheet (quarterly, 2025-09-30) — Receivables: 2083.00
CNS.V balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -27169487.00
CNS.V income_statement (quarterly, 2025-09-30) — Selling General And Administration: 4746.00
CNS.V balance_sheet (quarterly, 2025-09-30) — Share Issued: 94036835.00
CNS.V balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: -1744283.00
CNS.V balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: -1744283.00
CNS.V income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
CNS.V income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.00
CNS.V balance_sheet (quarterly, 2025-09-30) — Total Assets: 7181.00
CNS.V balance_sheet (quarterly, 2025-09-30) — Total Capitalization: -1744283.00
CNS.V balance_sheet (quarterly, 2025-09-30) — Total Debt: 333000.00
CNS.V balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: -1744283.00
CNS.V income_statement (quarterly, 2025-09-30) — Total Expenses: 4746.00
CNS.V balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 1751464.00
CNS.V balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 0.00
CNS.V balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 0.00
CNS.V balance_sheet (quarterly, 2025-09-30) — Working Capital: -1744283.00
CNS.V income_statement (quarterly, 2025-12-31) — +Operating Expense: -2426.00
CNS.V income_statement (quarterly, 2025-12-31) — +Total Revenue: 0.00
CNS.V balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 794704.00
CNS.V income_statement (quarterly, 2025-12-31) — Basic Average Shares: 94036835.00
CNS.V income_statement (quarterly, 2025-12-31) — Basic EPS: 0.00
CNS.V cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 5098.00
CNS.V balance_sheet (quarterly, 2025-12-31) — Capital Stock: 22259191.00
CNS.V balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 2462.00
CNS.V balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 2462.00
CNS.V balance_sheet (quarterly, 2025-12-31) — Cash Financial: 2462.00
CNS.V cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: -6877.00
CNS.V cash_flow (quarterly, 2025-12-31) — Change In Account Payable: -8947.00
CNS.V cash_flow (quarterly, 2025-12-31) — Change In Accrued Expense: 6016.00
CNS.V cash_flow (quarterly, 2025-12-31) — Change In Interest Payable: 6016.00
CNS.V cash_flow (quarterly, 2025-12-31) — Change In Payable: -8947.00
CNS.V cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: -2931.00
CNS.V cash_flow (quarterly, 2025-12-31) — Change In Receivables: -372.00
CNS.V cash_flow (quarterly, 2025-12-31) — Change In Working Capital: -3303.00
CNS.V cash_flow (quarterly, 2025-12-31) — Changes In Account Receivables: -372.00
CNS.V cash_flow (quarterly, 2025-12-31) — Changes In Cash: -2636.00
CNS.V balance_sheet (quarterly, 2025-12-31) — Common Stock: 22259191.00
CNS.V balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: -1747857.00
CNS.V balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 125967.00
CNS.V balance_sheet (quarterly, 2025-12-31) — Current Assets: 4917.00
CNS.V balance_sheet (quarterly, 2025-12-31) — Current Debt: 333000.00
CNS.V balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 333000.00
CNS.V balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 1752774.00
CNS.V income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 94036835.00
CNS.V income_statement (quarterly, 2025-12-31) — Diluted EPS: 0.00
CNS.V income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: -3574.00
CNS.V balance_sheet (quarterly, 2025-12-31) — Dueto Related Parties Current: 499103.00
CNS.V income_statement (quarterly, 2025-12-31) — EBIT: 2426.00
CNS.V income_statement (quarterly, 2025-12-31) — EBITDA: 2426.00
CNS.V cash_flow (quarterly, 2025-12-31) — End Cash Position: 2462.00
CNS.V cash_flow (quarterly, 2025-12-31) — Free Cash Flow: -6877.00
CNS.V balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 3166013.00
CNS.V income_statement (quarterly, 2025-12-31) — General And Administrative Expense: -2426.00
CNS.V income_statement (quarterly, 2025-12-31) — Interest Expense: 6000.00
CNS.V income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 6000.00
CNS.V balance_sheet (quarterly, 2025-12-31) — Interest Payable: 125967.00
CNS.V balance_sheet (quarterly, 2025-12-31) — Invested Capital: -1414857.00
CNS.V balance_sheet (quarterly, 2025-12-31) — Net Debt: 330538.00
CNS.V income_statement (quarterly, 2025-12-31) — Net Income: -3574.00
CNS.V income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: -3574.00
CNS.V income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: -3574.00
CNS.V income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -3574.00
CNS.V income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -3574.00
CNS.V cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: -3574.00
CNS.V income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: -3574.00
CNS.V income_statement (quarterly, 2025-12-31) — Net Interest Income: -6000.00
CNS.V income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -6000.00
CNS.V balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: -1747857.00
CNS.V income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 2426.00
CNS.V income_statement (quarterly, 2025-12-31) — Normalized Income: -3574.00
CNS.V cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: -6877.00
CNS.V income_statement (quarterly, 2025-12-31) — Operating Income: 2426.00
CNS.V income_statement (quarterly, 2025-12-31) — Operating Revenue: 0.00
CNS.V balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 94036835.00
CNS.V balance_sheet (quarterly, 2025-12-31) — Other Current Borrowings: 333000.00
CNS.V income_statement (quarterly, 2025-12-31) — Other Gand A: -2426.00
CNS.V balance_sheet (quarterly, 2025-12-31) — Other Receivables: 2455.00
CNS.V balance_sheet (quarterly, 2025-12-31) — Payables: 1293807.00
CNS.V balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 1419774.00
CNS.V income_statement (quarterly, 2025-12-31) — Pretax Income: -3574.00
CNS.V balance_sheet (quarterly, 2025-12-31) — Receivables: 2455.00
CNS.V balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -27173061.00
CNS.V income_statement (quarterly, 2025-12-31) — Selling General And Administration: -2426.00
CNS.V balance_sheet (quarterly, 2025-12-31) — Share Issued: 94036835.00
CNS.V balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: -1747857.00
CNS.V balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: -1747857.00
CNS.V income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
CNS.V income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.00
CNS.V balance_sheet (quarterly, 2025-12-31) — Total Assets: 4917.00
CNS.V balance_sheet (quarterly, 2025-12-31) — Total Capitalization: -1747857.00
CNS.V balance_sheet (quarterly, 2025-12-31) — Total Debt: 333000.00
CNS.V balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: -1747857.00
CNS.V income_statement (quarterly, 2025-12-31) — Total Expenses: -2426.00
CNS.V balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 1752774.00
CNS.V balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 0.00
CNS.V balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 0.00
CNS.V balance_sheet (quarterly, 2025-12-31) — Working Capital: -1747857.00
CNSD.L balance_sheet (annual, 2021-12-31) — Assets Held For Sale Current: 315557000.00
CNSD.L cash_flow (annual, 2021-12-31) — Sale Of Investment Properties: 60185000.00
CNSD.L income_statement (annual, 2022-12-31) — +Operating Expense: 13633442000.00
CNSD.L income_statement (annual, 2022-12-31) — +Total Revenue: 449567488000.00
CNSD.L balance_sheet (annual, 2022-12-31) — Accounts Payable: 14612499000.00
CNSD.L balance_sheet (annual, 2022-12-31) — Accounts Receivable: 11429907000.00
CNSD.L balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 40275115000.00
CNSD.L cash_flow (annual, 2022-12-31) — Amortization Cash Flow: 258594000.00
CNSD.L balance_sheet (annual, 2022-12-31) — Assets Held For Sale Current: 0.00
CNSD.L balance_sheet (annual, 2022-12-31) — Available For Sale Securities: 50966734000.00
CNSD.L income_statement (annual, 2022-12-31) — Basic Average Shares: 770735100.00
CNSD.L income_statement (annual, 2022-12-31) — Basic EPS: 23.00
CNSD.L cash_flow (annual, 2022-12-31) — Beginning Cash Position: 20728180000.00
CNSD.L cash_flow (annual, 2022-12-31) — Capital Expenditure: -31957911000.00
CNSD.L balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 10982687000.00
CNSD.L balance_sheet (annual, 2022-12-31) — Capital Stock: 157731290000.00
CNSD.L balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 30419297000.00
CNSD.L balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 47219250000.00
CNSD.L cash_flow (annual, 2022-12-31) — Cash Dividends Paid: -48872707000.00
CNSD.L cash_flow (annual, 2022-12-31) — Change In Inventory: -7900052000.00
CNSD.L cash_flow (annual, 2022-12-31) — Change In Other Current Assets: -4582434000.00
CNSD.L cash_flow (annual, 2022-12-31) — Change In Other Current Liabilities: -1167621000.00
CNSD.L cash_flow (annual, 2022-12-31) — Change In Payable: -15004136000.00
CNSD.L cash_flow (annual, 2022-12-31) — Change In Receivables: 8179674000.00
CNSD.L cash_flow (annual, 2022-12-31) — Change In Working Capital: -21673927000.00
CNSD.L cash_flow (annual, 2022-12-31) — Changes In Cash: 2356623000.00
CNSD.L balance_sheet (annual, 2022-12-31) — Common Stock: 157348610000.00
CNSD.L balance_sheet (annual, 2022-12-31) — Common Stock Equity: 319519547000.00
CNSD.L cash_flow (annual, 2022-12-31) — Common Stock Payments: 0.00
CNSD.L income_statement (annual, 2022-12-31) — Cost Of Revenue: 417665025000.00
CNSD.L balance_sheet (annual, 2022-12-31) — Current Assets: 211198563000.00
CNSD.L balance_sheet (annual, 2022-12-31) — Current Capital Lease Obligation: 1255361000.00
CNSD.L balance_sheet (annual, 2022-12-31) — Current Debt: 106640058000.00
CNSD.L balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 107895419000.00
CNSD.L balance_sheet (annual, 2022-12-31) — Current Liabilities: 166446346000.00
CNSD.L balance_sheet (annual, 2022-12-31) — Current Provisions: 5737290000.00
CNSD.L cash_flow (annual, 2022-12-31) — Depreciation: 34090752000.00
CNSD.L cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 34349346000.00
CNSD.L balance_sheet (annual, 2022-12-31) — Derivative Product Liabilities: 1046631000.00
CNSD.L income_statement (annual, 2022-12-31) — Diluted Average Shares: 773842500.00
CNSD.L income_statement (annual, 2022-12-31) — Diluted EPS: 23.00
CNSD.L income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: 17783775000.00
CNSD.L cash_flow (annual, 2022-12-31) — Dividends Received Cfi: 3230336000.00
CNSD.L income_statement (annual, 2022-12-31) — EBIT: 25752003000.00
CNSD.L income_statement (annual, 2022-12-31) — EBITDA: 60101349000.00
CNSD.L cash_flow (annual, 2022-12-31) — Effect Of Exchange Rate Changes: 3338616000.00
CNSD.L cash_flow (annual, 2022-12-31) — End Cash Position: 26423419000.00
CNSD.L balance_sheet (annual, 2022-12-31) — Financial Assets: 814630000.00
CNSD.L balance_sheet (annual, 2022-12-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 869532000.00
CNSD.L cash_flow (annual, 2022-12-31) — Financing Cash Flow: 2601937000.00
CNSD.L cash_flow (annual, 2022-12-31) — Free Cash Flow: -7614726000.00
CNSD.L cash_flow (annual, 2022-12-31) — Gain Loss On Investment Securities: -2905716000.00
CNSD.L cash_flow (annual, 2022-12-31) — Gain Loss On Sale Of PPE: -386983000.00
CNSD.L income_statement (annual, 2022-12-31) — General And Administrative Expense: 6942993000.00
CNSD.L balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 1343993000.00
CNSD.L balance_sheet (annual, 2022-12-31) — Gross Accounts Receivable: 11429907000.00
CNSD.L balance_sheet (annual, 2022-12-31) — Gross PPE: 382572024000.00
CNSD.L income_statement (annual, 2022-12-31) — Gross Profit: 31902463000.00
CNSD.L balance_sheet (annual, 2022-12-31) — Hedging Assets Current: 3125323000.00
CNSD.L income_statement (annual, 2022-12-31) — Interest Expense: 2493407000.00
CNSD.L income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 2493407000.00
CNSD.L income_statement (annual, 2022-12-31) — Interest Income: 469573000.00
CNSD.L income_statement (annual, 2022-12-31) — Interest Income Non Operating: 469573000.00
CNSD.L cash_flow (annual, 2022-12-31) — Interest Paid Cff: -2841083000.00
CNSD.L cash_flow (annual, 2022-12-31) — Interest Received Cfi: 459870000.00
CNSD.L balance_sheet (annual, 2022-12-31) — Inventory: 131515763000.00
CNSD.L balance_sheet (annual, 2022-12-31) — Invested Capital: 554411382000.00
CNSD.L cash_flow (annual, 2022-12-31) — Investing Cash Flow: -24588499000.00
CNSD.L balance_sheet (annual, 2022-12-31) — Investment Properties: 9759107000.00
CNSD.L balance_sheet (annual, 2022-12-31) — Investmentin Financial Assets: 51836266000.00
CNSD.L cash_flow (annual, 2022-12-31) — Issuance Of Debt: 590621503000.00
CNSD.L balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 9727326000.00
CNSD.L balance_sheet (annual, 2022-12-31) — Long Term Debt: 128251777000.00
CNSD.L balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 137979103000.00
CNSD.L cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 132814334000.00
CNSD.L cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -113032130000.00
CNSD.L balance_sheet (annual, 2022-12-31) — Long Term Equity Investment: 14565313000.00
CNSD.L balance_sheet (annual, 2022-12-31) — Long Term Provisions: 821937000.00
CNSD.L balance_sheet (annual, 2022-12-31) — Minority Interest: 36943217000.00
CNSD.L income_statement (annual, 2022-12-31) — Minority Interests: -211284000.00
CNSD.L cash_flow (annual, 2022-12-31) — Net Business Purchase And Sale: 126377000.00
CNSD.L cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: 0.00
CNSD.L balance_sheet (annual, 2022-12-31) — Net Debt: 204472538000.00
CNSD.L income_statement (annual, 2022-12-31) — Net Income: 17783775000.00
CNSD.L income_statement (annual, 2022-12-31) — Net Income Common Stockholders: 17783775000.00
CNSD.L income_statement (annual, 2022-12-31) — Net Income Continuous Operations: 17995059000.00
CNSD.L income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: 17783775000.00
CNSD.L income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: 17783775000.00
CNSD.L cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: 23258596000.00
CNSD.L income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: 17995059000.00
CNSD.L cash_flow (annual, 2022-12-31) — Net Intangibles Purchase And Sale: -79745000.00
CNSD.L income_statement (annual, 2022-12-31) — Net Interest Income: -2023834000.00
CNSD.L cash_flow (annual, 2022-12-31) — Net Investment Properties Purchase And Sale: -188553000.00
CNSD.L cash_flow (annual, 2022-12-31) — Net Investment Purchase And Sale: 948513000.00
CNSD.L cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: 59018521000.00
CNSD.L cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: 19782204000.00
CNSD.L income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: -2023834000.00
CNSD.L cash_flow (annual, 2022-12-31) — Net Other Financing Charges: -3504217000.00
CNSD.L cash_flow (annual, 2022-12-31) — Net Other Investing Changes: 1573204000.00
CNSD.L balance_sheet (annual, 2022-12-31) — Net PPE: 382572024000.00
CNSD.L cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -30658501000.00
CNSD.L cash_flow (annual, 2022-12-31) — Net Short Term Debt Issuance: 39236317000.00
CNSD.L balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 318558234000.00
CNSD.L balance_sheet (annual, 2022-12-31) — Non Current Deferred Revenue: 37575000.00
CNSD.L balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Assets: 8262336000.00
CNSD.L balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Liabilities: 13757387000.00
CNSD.L balance_sheet (annual, 2022-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 5605470000.00
CNSD.L balance_sheet (annual, 2022-12-31) — Non Current Prepaid Assets: 1070477000.00
CNSD.L income_statement (annual, 2022-12-31) — Normalized EBITDA: 60105017000.00
CNSD.L income_statement (annual, 2022-12-31) — Normalized Income: 17786612913.19
CNSD.L cash_flow (annual, 2022-12-31) — Operating Cash Flow: 24343185000.00
CNSD.L income_statement (annual, 2022-12-31) — Operating Income: 18269021000.00
CNSD.L income_statement (annual, 2022-12-31) — Operating Revenue: 449567488000.00
CNSD.L balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 15452970000.00
CNSD.L balance_sheet (annual, 2022-12-31) — Other Current Assets: 6674611000.00
CNSD.L balance_sheet (annual, 2022-12-31) — Other Current Liabilities: 3863261000.00
CNSD.L balance_sheet (annual, 2022-12-31) — Other Equity Interest: -4844120000.00
CNSD.L cash_flow (annual, 2022-12-31) — Other Non Cash Items: 874841000.00
CNSD.L balance_sheet (annual, 2022-12-31) — Other Non Current Assets: 2346688000.00
CNSD.L balance_sheet (annual, 2022-12-31) — Other Non Current Liabilities: 1229504000.00
CNSD.L income_statement (annual, 2022-12-31) — Other Non Operating Income Expenses: 5438344000.00
CNSD.L balance_sheet (annual, 2022-12-31) — Other Payable: 26024196000.00
CNSD.L balance_sheet (annual, 2022-12-31) — Other Properties: 382572024000.00
CNSD.L balance_sheet (annual, 2022-12-31) — Other Receivables: 11154021000.00
CNSD.L balance_sheet (annual, 2022-12-31) — Other Short Term Investments: 16799953000.00
CNSD.L income_statement (annual, 2022-12-31) — Otherunder Preferred Stock Dividend: 0.00